Photodynamic Therapy with Tumor Cell Discrimination through RNA-Targeting Ability of Photosensitizer

Area of Science:

• Biochemistry
• Nanotechnology
• Oncology

Background:

• Photodynamic therapy (PDT) is a promising cancer treatment.
• Effective PDT relies on photosensitizers that selectively target cancer cells.
• Current methods for targeting cancer cells are complex and may lack efficacy.

Purpose of the Study:

• To develop a novel photosensitizer, QICY, with RNA-targeting capabilities for cancer cell discrimination.
• To investigate the potential of RNA content differences between cancer and normal cells for targeted therapy.
• To enhance PDT efficacy by improving cancer cell targeting and reducing side effects.

Main Methods:

• Synthesis of QICY, a photosensitizer designed to interact with RNA.
• Evaluation of QICY's localization in cancer versus normal cells based on RNA electrostatic interactions.
• In vivo studies using mice with xenograft tumors to assess QICY's accumulation, targeting, and therapeutic effects under laser irradiation.

Main Results:

• QICY demonstrated specific localization in cancer cells due to stronger electrostatic interactions with RNA.
• The enhanced permeability and retention (EPR) effect facilitated QICY accumulation in tumors.
• QICY effectively inhibited tumor growth with 630 nm laser irradiation, showing minimal side effects.

Conclusions:

• QICY functions as an intelligent photosensitizer by leveraging RNA content differences for cancer cell targeting.
• This RNA-targeting strategy simplifies the design of targeted photosensitizers for PDT.
• The developed approach shows significant potential for advancing the efficacy of photodynamic therapy for cancer treatment.